Inflammatory myopathies

Self-efficacy in idiopathic inflammatory myopathies: associated factors, profiles and patient-reported outcomes

Rheumatology (Oxford)Published Cross-sectional study

Authors' conclusion

SE in IIMs is associated with modifiable socioeconomic and psychological factors and with better health outcomes.

Study context

Population
Participants with idiopathic inflammatory myopathies (IIMs), other rheumatic diseases and non-rheumatic autoimmune diseases
Participants
5,802 participants
Exposure
IIM vs other rheumatic diseases (RMDs) vs non-rheumatic autoimmune diseases
Outcome
Self-efficacy measured by the Self-Efficacy for Managing Chronic Disease (SEMCD) scale
Methodological detailshierarchical regression, k-means clustering, multivariable model
  • Hierarchical regression
  • K-means clustering
  • Multivariable model

Main finding

As reported in the abstract

SE (SEMCD), median

IIM

5.3

median

RMDs

5.8

Non-rheumatic autoimmune diseases (nRAIDs)

6.5

Observational data: associations, not effects.

Further findings

Factors associated with SE, fully adjusted integrated model

Model R²
0.222
Mental health comorbidity, B
−0.898
Financial difficulty, B
−0.734
Regular exercise, B
0.770
Family support, B
0.150

PRO model of SE

SE variance explained (R²)
0.483
Resilience strongest positive association; fatigue and pain negatively associated

SE health profiles

Four SE profiles identified; resilient-despite-burden subgroup
24%
  • High symptom burden but preserved SE and mental health

Higher SE and patient-reported outcomes (PROs)

Higher SE associated with better physical and mental health, greater resilience and life satisfaction, lower fatigue, pain and loneliness
all P < 0.001

Original publication

Self-efficacy in idiopathic inflammatory myopathies: associated factors, profiles and patient-reported outcomes. Rheumatology (Oxford). Published 25 August 2026. doi:10.1093/rheumatology/keag458

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.